Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $4.3B |
| Sales growthchange from the year before | +2.9% |
| Gross marginshare of sales left after the direct cost of what it sells | 26.5% |
| Operating marginshare of sales left after running the business | 22.7% |
| Net marginshare of sales kept as profit | 12.6% |
| Return on invested capitalprofit made on each $100 put into the business | 11.4% |
| Return on equityprofit vs. shareholders' accounting value | 33.1% |
| Debt / equitydebt vs. shareholders' accounting value | 3.14 |
| Interest coverhow many times profit covers interest payments | 3.8x |
| Change in share countnegative = the company is buying back its shares | -2.8% |
3 insiders sold $28.4M on the open market.
| Tanzberger Eric DExec. VP, and CFO | SoldAug 3 | 54,800 shat $86.04 · $4.7M |
| Faulk John HSvp, Coo | SoldJul 31 | 24,600 shat $85.65 · $2.1M |
| Ryan Thomas LCEO & Chairman · Director | SoldJul 31 | 253,391 shat $85.25 · $21.6M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy